Why is everybody so focused on the coronavirus vaccine instead of looking at the company's entire portfolio? MRNA has so many products that are ready to launch either now or in the next five years. I don't understand how can investors miss such... — read more
Buy the dip
If you were waiting for Moderna to go down to join the fun, now's the time. It's still high, but it is at least 40 percent under its all-time high. This is not a move for those who are looking for short-term investments, but if you're looking to add... — read more
It's not stopping!
You love to see it, especially if you were smart enough or lucky enough to buy it when it was down to $230. It gained more than 11 percent just today. With the Omicron threat hanging over our heads and the latest vaccine prediction, Moderna is as... — read more
Going up once again
I'm never too quick to give up on pharmaceutical and biotechnology companies and I won't do that now. MRNA is already climbing once again. I see that some expected stellar results, but if people learned to manage their expectations, they'd be much... — read more
I was hoping for so much more
I have to admit I had big expectations when it comes to Moderna. I can't even figure out why its vaccine didn't take off as well as Pfizer's. Both are mRNA vaccines, it arrived shortly after the Pfizer one... I was going to hold on to this one but... — read more